1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Bioproduction Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Bioproduction Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Bioproduction Market Regional Analysis
6.2 Middle East & Africa Bioproduction Market Revenue 2020-2030 (US$ Million)
6.3 Middle East & Africa Bioproduction Market Forecast Analysis
7. Middle East & Africa Bioproduction Market Analysis – by Product
7.1 Biologics and Biosimilars
- 7.1.1 Overview
- 7.1.2 Biologics and Biosimilars: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Vaccines
- 7.2.1 Overview
- 7.2.2 Vaccines: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Cell and Gene Therapies
- 7.3.1 Overview
- 7.3.2 Cell and Gene Therapies: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Nucleic Acid Therapeutics
- 7.4.1 Overview
- 7.4.2 Nucleic Acid Therapeutics: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Middle East & Africa Bioproduction Market Analysis – by Application
8.1 Rheumatoid Arthritis
- 8.1.1 Overview
- 8.1.2 Rheumatoid Arthritis: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Hematological Disorders
- 8.2.1 Overview
- 8.2.2 Hematological Disorders: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Cancer
- 8.3.1 Overview
- 8.3.2 Cancer: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Diabetes
- 8.4.1 Overview
- 8.4.2 Diabetes: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Cardiovascular Diseases
- 8.5.1 Overview
- 8.5.2 Cardiovascular Diseases: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Middle East & Africa Bioproduction Market Analysis – by Equipment
9.1 Upstream Equipment
- 9.1.1 Overview
- 9.1.2 Upstream Equipment: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Downstream Equipment
- 9.2.1 Overview
- 9.2.2 Downstream Equipment: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Bioreactors
- 9.3.1 Overview
- 9.3.2 Bioreactors: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Consumables and Accessories
- 9.4.1 Overview
- 9.4.2 Consumables and Accessories: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Middle East & Africa Bioproduction Market Analysis – by End User
10.1 Biopharmaceutical Companies
- 10.1.1 Overview
- 10.1.2 Biopharmaceutical Companies: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Contract Manufacturing Organizations
- 10.2.1 Overview
- 10.2.2 Contract Manufacturing Organizations: Middle East & Africa Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Middle East & Africa Bioproduction Market – Middle East and Africa Analysis
11.1 Overview
11.2 Middle East and Africa
- 11.2.1 Middle East & Africa Bioproduction Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 Middle East & Africa Bioproduction Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 South Africa:
Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 South Africa: Middle East & Africa Bioproduction Market Breakdown, by Product
- 11.2.1.1.2 South Africa: Middle East & Africa Bioproduction Market Breakdown, by Application
- 11.2.1.1.3 South Africa: Middle East & Africa Bioproduction Market Breakdown, by Equipment
- 11.2.1.1.4 South Africa: Middle East & Africa Bioproduction Market Breakdown, by End User
- 11.2.1.2 Saudi Arabia:
Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Saudi Arabia: Middle East & Africa Bioproduction Market Breakdown, by Product
- 11.2.1.2.2 Saudi Arabia: Middle East & Africa Bioproduction Market Breakdown, by Application
- 11.2.1.2.3 Saudi Arabia: Middle East & Africa Bioproduction Market Breakdown, by Equipment
- 11.2.1.2.4 Saudi Arabia: Middle East & Africa Bioproduction Market Breakdown, by End User
- 11.2.1.3 UAE:
Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 UAE: Middle East & Africa Bioproduction Market Breakdown, by Product
- 11.2.1.3.2 UAE: Middle East & Africa Bioproduction Market Breakdown, by Application
- 11.2.1.3.3 UAE: Middle East & Africa Bioproduction Market Breakdown, by Equipment
- 11.2.1.3.4 UAE: Middle East & Africa Bioproduction Market Breakdown, by End User
- 11.2.1.4 Rest of Middle East and Africa:
Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Bioproduction Market Breakdown, by Product
- 11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Bioproduction Market Breakdown, by Application
- 11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Bioproduction Market Breakdown, by Equipment
- 11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Bioproduction Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Lonza Group AG
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Danaher Corp
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Sartorius AG
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Thermo Fisher Scientific Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Merck KGaA
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 F. Hoffmann-La Roche Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Bio-Rad Laboratories Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations